menu
    • menu

    Company profile for Alvogen

    NEW Drugs in Dev: 18
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Alvogen is a privately held next-generation pharmaceuticals company. Its business model ensures competitive advantage through focused in-house capabilities combined with a network of partners for enhanced speed and flexibility. A unique portfolio of high quality and high barrier products fuels our targeted growth strategy. Currently, Alvogen is present in 30 countries around the world with over 200 strategically selected pharm...
    Alvogen is a privately held next-generation pharmaceuticals company. Its business model ensures competitive advantage through focused in-house capabilities combined with a network of partners for enhanced speed and flexibility. A unique portfolio of high quality and high barrier products fuels our targeted growth strategy. Currently, Alvogen is present in 30 countries around the world with over 200 strategically selected pharmaceutical projects in development and registration covering key therapeutic areas including biosimilars.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AlvogenUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Alvogen US10 Bloomfield AvenuePine BrookNJ 07058 U.S.A.
    Telephone
    Telephone
    1 973 796 3400
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.alvogen.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enforcement Report - Week of January 21, 2026
    Enforcement Report - Week of January 21, 2026

    21 Jan 2026

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-21-2026-24128.pdf

    FDA
    21 Jan 2026
    Share Share
    Lotus Grows US Generics Business With Acquisition Of Alvogen
    Lotus Grows US Generics Business With Acquisition Of Alvogen

    26 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/alvogen-announces-sale-to-lotus-creating-a-leading-international-specialized-generics-platform-302564869.html

    PR NEWSWIRE
    26 Sep 2025
    Share Share
    Alvogen Sells To Lotus, Forming Top Global Specialized Generics
    Alvogen Sells To Lotus, Forming Top Global Specialized Generics

    23 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/alvogen-announces-sale-to-lotus-creating-a-leading-international-specialized-generics-platform-302564869.html

    PR NEWSWIRE
    23 Sep 2025
    Share Share
    Alvogen Completes Comprehensive Refinancing
    Alvogen Completes Comprehensive Refinancing

    07 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/alvogen-completes-comprehensive-refinancing-302396066.html

    PR NEWSWIRE
    07 Mar 2025
    Share Share
    Enforcement Report - Week of February 26, 2025
    Enforcement Report - Week of February 26, 2025

    26 Feb 2025

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-26-2025-78017.pdf

    FDA
    26 Feb 2025
    Share Share
    Alvogen Issues Voluntary Nationwide Recall for Fentanyl Transdermal
    Alvogen Issues Voluntary Nationwide Recall for Fentanyl Transdermal

    31 Jan 2025

    // FDA

    https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/alvogen-issues-voluntary-nationwide-recall-one-lot-fentanyl-transdermal-system-25-mcgh-due-defective

    FDA
    31 Jan 2025
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Alvogen and get a quotation

    Alvogen is a supplier offers 2 products (APIs, Excipients or Intermediates).

    Find a price of Furaltadone HCl bulk offered by Alvogen

    Find a price of Mesalazine bulk offered by Alvogen

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search